Validation and Reliability of the Vietnamese Pain Self-Efficacy Questionnaire in Knee Osteoarthritis
1 other identifier
observational
173
1 country
1
Brief Summary
This study aims to evaluate the reliability and convergent validity of the Vietnamese version of the Pain Self-Efficacy Questionnaire (VIET-PSEQ) in patients with knee osteoarthritis (KOA). Pain self-efficacy refers to a person's confidence in managing their pain and maintaining daily activities despite it. A total of 173 patients with KOA will be recruited at Gia Dinh People's Hospital using a convenient sampling method. Eligible participants are 50 years or older, diagnosed with KOA, and experiencing chronic knee pain. They will complete the VIET-PSEQ and other health-related questionnaires during an in-person interview. The study will assess internal consistency (using Cronbach's alpha), test-retest reliability (by re-assessing a subgroup after 72 hours), and convergent validity by correlating VIET-PSEQ scores with EQ-5D-5L utility index. Additionally, linear regression analysis will examine how age, sex, pain severity, and education level influence pain self-efficacy. The goal is to determine whether VIET-PSEQ is a reliable and valid tool for measuring pain self-efficacy in Vietnamese patients with KOA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2025
CompletedFirst Submitted
Initial submission to the registry
August 12, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 19, 2025
August 1, 2025
5 months
August 12, 2025
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Internal consistency and test-retest reliability of the Vietnamese version of the Pain Self-Efficacy Questionnaire (VIET-PSEQ)
The primary outcomes are the internal consistency and test-retest reliability of the Vietnamese version of the Pain Self-Efficacy Questionnaire (VIET-PSEQ) among patients with knee osteoarthritis. Internal consistency will be assessed using Cronbach's alpha with a threshold of ≥ 0.70. Test-retest reliability will be evaluated using the intraclass correlation coefficient (ICC) calculated from a two-way random-effects model with absolute agreement, based on repeated assessments 3 days apart without clinical intervention.
Baseline and follow-up at Day 3 for test-retest group
Secondary Outcomes (1)
Convergent validity of the VIET-PSEQ via correlation with EQ-5D-5L index score
At baseline assessment
Other Outcomes (1)
Regression analysis of predictors of total VIET PSEQ score
At baseline (upon enrollment)
Study Arms (1)
Patients with Knee Osteoarthritis
A single group of patients aged 50+ with clinically diagnosed knee osteoarthritis attending Gia Dinh People's Hospital for outpatient evaluation. Participants will complete the Vietnamese Pain Self-Efficacy Questionnaire (VIET-PSEQ) to assess its psychometric properties.
Interventions
Participants completed the Vietnamese version of the Pain Self-Efficacy Questionnaire (PSEQ) to assess self-efficacy beliefs related to pain management.
Eligibility Criteria
The study population will consist of adults aged 50 years and older diagnosed with knee osteoarthritis, either newly confirmed at the time of enrollment using the American College of Rheumatology (ACR) criteria or previously diagnosed and documented in the medical records by a specialist. Participants will be recruited from outpatient departments in urban hospitals in Vietnam. The population includes patients with chronic knee pain related to osteoarthritis who are able to perform daily activities and comprehend written Vietnamese.
You may qualify if:
- Age ≥ 50 years.
- Diagnosis of knee osteoarthritis (OA) according to the criteria of the American College of Rheumatology (ACR), confirmed by:
- application of ACR criteria by the investigator at the time of enrollment; or
- a prior diagnosis documented in medical records by a rheumatologist or musculoskeletal specialist.
- Presence of chronic pain related to knee OA, with current pain intensity ≥ 1 on the Visual Analog Scale (VAS).
- No acute flare of knee pain within the past 2 weeks.
- Ability to perform activities of daily living (with or without assistance).
- Ability to read, understand, and complete questionnaires in Vietnamese.
- Willingness to participate and provide informed consent.
You may not qualify if:
- Participants will be excluded if they meet any of the following conditions:
- Diagnosis of severe psychiatric disorders (e.g., schizophrenia, severe anxiety disorders).
- Presence of cognitive impairment that interferes with the ability to comprehend or answer the questionnaire.
- Diagnosed with systemic inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, or gout.
- Presence of other chronic pain conditions (unrelated to knee OA) that are predominant and significantly affect mobility and daily functioning.
- History of intra-articular injection or knee surgery within the past 3 months.
- Questionnaire (PSEQ) with ≥ 20% of items missing or invalid.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gia Dinh People's Hospital
Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Deputy Head, Department of Rehabilitation
Study Record Dates
First Submitted
August 12, 2025
First Posted
August 19, 2025
Study Start
July 14, 2025
Primary Completion
December 14, 2025
Study Completion
December 31, 2025
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- IPD and supporting documents will be available beginning 6 months after publication of the primary results. Data will remain accessible for a period of 5 years following this initial release.
- Access Criteria
- Qualified researchers affiliated with academic institutions or research organizations may access the data by submitting a data use request, including a brief proposal outlining research objectives, methodology, and intended outcomes. Data access is conditional upon signing a data-sharing agreement to ensure ethical use and data protection compliance.
Individual participant data (IPD) underlying the results of this study will be shared with other researchers upon reasonable request. The data will be de-identified to protect participant privacy and used solely for academic and non-commercial research purposes.